TCI Wealth Advisors Inc. Decreases Position in The Clorox Company (NYSE:CLX)

TCI Wealth Advisors Inc. cut its stake in shares of The Clorox Company (NYSE:CLX) by 22.1% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 10,554 shares of the company’s stock after selling 3,000 shares during the period. TCI Wealth Advisors Inc.’s holdings in Clorox were worth $1,714,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Brooklyn Investment Group grew its stake in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares in the last quarter. Prospera Private Wealth LLC acquired a new stake in shares of Clorox during the third quarter worth approximately $27,000. Continuum Advisory LLC increased its stake in shares of Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after buying an additional 138 shares during the last quarter. Quarry LP raised its holdings in Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after acquiring an additional 114 shares in the last quarter. Finally, Carolina Wealth Advisors LLC bought a new position in Clorox during the 3rd quarter valued at $48,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Shares of NYSE CLX opened at $160.28 on Friday. The firm’s 50-day simple moving average is $162.98 and its 200 day simple moving average is $158.03. The stock has a market cap of $19.84 billion, a P/E ratio of 55.85, a P/E/G ratio of 2.91 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same period last year, the firm posted $0.49 earnings per share. Equities analysts expect that The Clorox Company will post 6.86 EPS for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.04%. Clorox’s dividend payout ratio is currently 170.04%.

Wall Street Analysts Forecast Growth

CLX has been the topic of a number of recent analyst reports. Barclays cut their target price on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research note on Friday, January 17th. Evercore ISI decreased their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. JPMorgan Chase & Co. upped their price target on Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a research report on Thursday, January 16th. DA Davidson lifted their price objective on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Finally, TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their target price for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, Clorox presently has a consensus rating of “Hold” and a consensus target price of $156.07.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.